Zobrazeno 1 - 10
of 19
pro vyhledávání: '"C F, Yoshida"'
Publikováno v:
European journal of epidemiology. 17(2)
Hepatitis B vaccine is the most effective strategy for preventing the transmission of hepatitis B virus (HBV) in haemodialysis centers. Nevertheless, lower vaccine responses have been reported in haemodialysis patients as compared with healthy subjec
Publikováno v:
Revista da Sociedade Brasileira de Medicina Tropical. 34(1)
The objective of this investigation was to study the prevalence of serological markers of hepatitis B and possible risk factors for this disease in a sample of 404 people who attended a Testing and Couseling Center for HIV in the city of Ribeirão Pr
Publikováno v:
Journal of medical virology. 63(4)
Eight cases of de novo hepatitis C virus (HCV) infection in a haemodialysis unit in Rio de Janeiro, Brazil, were retrospectively studied. HCV viraemia was demonstrated by RT nested PCR in seven of the seroconverters. Genotyping showed that six patien
Publikováno v:
Revista de saude publica. 34(3)
To study some of the epidemiological aspects of hepatitis B in a non-representative sample of patients seen in health care clinics.The study population comprised 632 patients who were seen at health care clinics in the city of Ribeirão Preto, Brazil
Publikováno v:
Vox sanguinis. 78(4)
Autor:
R S, Ross, S, Viazov, U, Schmitt, S, Schmolke, M, Tacke, B, Ofenloch-Haehnle, M, Holtmann, N, Müller, G, Da Villa, C F, Yoshida, J M, Oliveira, A, Szabo, N, Paladi, J P, Kruppenbacher, T, Philipp, M, Roggendorf
Publikováno v:
Journal of medical virology. 54(2)
Since the identification of the new human virus, GB virus C (GBV-C)/hepatitis G-virus (HGV), in 1995/1996, reverse transcription polymerase chain reaction remained the sole available diagnostic tool for GBV-C/HGV infection. Recently, a serologic test
Publikováno v:
Journal of medical virology. 52(1)
Recently, sequences from a novel human flavivirus, termed GB virus C (GBV-C) or hepatitis G virus (HGV), have been identified in serum from patients with cryptogenic hepatitis and others. Sera from 116 patients with different clinical backgrounds wer
Autor:
A V, Naghettini, R R, Daher, R M, Martin, J, Doles, B, Vanderborght, C F, Yoshida, C, Rouzere
Publikováno v:
Revista da Sociedade Brasileira de Medicina Tropical. 30(2)
The patients were 173, aged 10 to 70 years old. An Elisa II test was undertaken and 61 to 173 (35.3%) had positive test; when INNO-LIA test was made, soropositivity was 26% (44/173). Patients with anti-VHC antibodies have been kept on hemodialysis tr
Publikováno v:
Acta virologica. 40(5-6)
A Western blot assay was standardized to evaluate the antigenic reactivity of hepatitis B virus (HBV) strains circulating in Brazilian population with antibodies raised against recombinant hepatitis B (HB) vaccines. In this assay, HBV envelope protei
Publikováno v:
Acta virologica. 40(3)
The presence of hepatitis B virus (HBV) DNA was investigated by polymerase chain reaction (PCR) in the serum of twenty Brazilian blood donors. All sera were negative for hepatitis B surface antigen (HBsAg), 17 of them presented antibodies to the hepa